| Revenue growth | 66.7% YoY growth driven by international expansion and Complan acquisition. |
|---|---|
| Margins | EBITDA grew 55.3%; margins supported by premiumization and Complan integration. |
| Demand visibility | Resilient demand in personal care; weather-dependent volatility in seasonal brands. |
| Management confidence | Balanced; optimistic on portfolio diversification despite seasonal brand volatility. |
Growth
Reported sales hit 14,299 million; Complan delivered 24.8% growth while organic domestic grew 4.6%.
Outlook
Management targets continued double-digit growth in international business and recovery in seasonal brand momentum.
Risks
Seasonal dependency remains a trigger; Glucon-D and Nycil struggled due to unseasonal summer rains.
Last quarter's promises, checked
Delivered
- Comfort Click EPS accretion → Delivered EPS accretive in Q4 (= BEAT)
- Everyuth double-digit growth → Delivered strong double-digit FY26 growth (= BEAT)
- Sugar Free Green 20th consecutive double-digit growth quarter → Delivered (= BEAT)
Partly delivered
- 17-18% EBITDA margin target → Reported FY26 EBITDA growth but still working toward target (= PARTIAL)
Missed
- Seasonal brand recovery → Delivered 9.8% decline in Q4 (= MISS)
Earnings Call Transcript filed with NSE, NSE: ZYDUSWELL. Summary written with AI assistance from the document.
Zydus Wellness Ltd: key numbers
- Share price
- ₹520.60
- Market cap
- ₹16,563 Cr
- Revenue (annual)
- ₹3,961 Cr
- Net profit (annual)
- ₹197.2 Cr
- P/E (TTM)
- 88.0×Sector 43.4×
- Promoter holding
- 69.64%+0.01% QoQ
- FII holding
- 3.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Wellness Ltd
All →Zydus Wellness Management Change
Zydus Wellness Limited announced the resignation of Mr. Arijit Sengupta, Chief Marketing Officer, effective September 18, 2026.
Zydus Wellness Price Movement Clarification
Zydus Wellness clarified to NSE that the spurt in volume is purely market-driven with no undisclosed information. The company confirmed all Reg 30 disclosures have been made.
Zydus Wellness Other Announcement
Zydus Wellness Ltd has received an ESG score of 71.7 from SES ESG Research Pvt. Ltd., improving from the previous score of 70.
Zydus Wellness Annual General Meeting
Zydus Wellness Limited has filed the transcript of its 32nd Annual General Meeting held on August 4, 2026. This document records the proceedings of the meeting.
Zydus Wellness Investor Presentation: Key Takeaways
Zydus Wellness Q1 FY27 earnings presentation highlights strong double-digit growth in core portfolios like Sugar Free and Everyuth, despite weather-related headwinds impacting seasonal brands like Glucon-D and Nycil.
Zydus Wellness Q1 FY27 Results: Net Profit ₹118.9 Cr, Down 7.0% YoY
Zydus Wellness Ltd reported revenue from operations of ₹1,437 Cr (+66.9% YoY) and net profit of ₹118.9 Cr (-7.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹118.9 Cr · -7.0% YoY